Digestive/GI side effects are common: nausea, vomiting, diarrhea, constipation, delayed gastric emptying (gastroparesis) have all been documented
They found that for FDA approved GLP-1s for weight loss, liraglutide (Saxenda) and semaglutide (Wegovy), the percent of side effects reported was as follows: Nausea: 42.2% Diarrhea: 21.9% Vomiting: also 21.9% Constipation: 8.4% They report that although the incidence of side effects were similar among medications, semaglutide had the greatest risk of nausea, diarrhea, and vomiting, whereas liraglutide had the greatest risk of upper abdominal pain
Jeff Manley isnt just our owner hes also a living testament to the effectiveness of our weight loss management program
AST , aspartate aminotransferase
[Real Clinical Citations] We include 13 clinical citations
Use our call script to verify with BCBS Check the 2026 outlook for your state Not Sure Which Applies